NEW YORK (GenomeWeb News) – Claire Fraser-Ligget and Steven St. Peter will not stand for re-election as directors of Helicos Biosciences at the company’s upcoming May stockholder’s meeting, according to a filing with the US Securities and Exchange Commission.
Until the annual meeting, St. Peter will continue as a member of the Nominating and Corporate Governance Committee and Fraser-Liggett will continue to serve as a member of the Compensation Committee
Helicos said that neither of the individuals made their decision due to any disagreement with the company.
Paul Cochran has joined BioTrove as senior VP of human resources. Cochran formerly was involved in diagnostic services and in human resources at CIBA-Corning Diagnostics.
BioReliance has tapped John Kolman to take over the post of senior director of research and development. Kolman formerly worked for Invitrogen as principal scientist on the HLA Single Antigen Initiative and lung cancer biomarker programs. He also studied DNA replication initiation at the Salk Institute.
Danong Chen has been elected as the new president and CEO of Theranostics Health. Chen was previously the president and CEO of Tanox, a publicly held biopharmaceutical company that was acquired by Genentech in 2007.
Prior to her tenure at Tanox she served as a manager in the health care practice section at Arthur D. Little. Chen also holds a PhD from Baylor College of Medicine as well as an MBA from Arthur D. Little School of Management in Boston.
Michael Treble has been elected chairman of Axela’s board, the company said this week.
Treble has been a director and member of Axela’s audit committee since 2004. He is currently president of Ibis BioSciences, and was formerly COO and director of Third Wave Technologies, and president and CEO of NimbleGen Systems.
Axela is a privately held protein interaction firm based in Toronto.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in PEOPLE, a weekly roundup of industry comings and goings.